tiprankstipranks
Blurbs

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Amedisys (AMED), Mirati Therapeutics (MRTX) and Ayr Wellness (OtherAYRWF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amedisys (AMEDResearch Report), Mirati Therapeutics (MRTXResearch Report) and Ayr Wellness (AYRWFResearch Report).

Amedisys (AMED)

SVB Securities analyst Whit Mayo maintained a Hold rating on Amedisys today and set a price target of $117.00. The company’s shares closed last Thursday at $117.39, close to its 52-week low of $109.53.

According to TipRanks.com, Mayo is a 4-star analyst with an average return of 6.2% and a 52.4% success rate. Mayo covers the Healthcare sector, focusing on stocks such as Airsculpt Technologies, Inc., Alignment Healthcare, and Privia Health Group.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Amedisys with a $175.44 average price target.

See Insiders’ Hot Stocks on TipRanks >>

Mirati Therapeutics (MRTX)

In a report released today, Andrew Berens from SVB Securities maintained a Buy rating on Mirati Therapeutics, with a price target of $111.00. The company’s shares closed last Thursday at $58.46, close to its 52-week low of $51.16.

According to TipRanks.com, Berens has currently 0 stars on a ranking scale of 0-5 stars, with an average return of -11.8% and a 37.0% success rate. Berens covers the Healthcare sector, focusing on stocks such as Forma Therapeutics Holdings, Turning Point Therapeutics, and Deciphera Pharmaceuticals.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Mirati Therapeutics with a $138.30 average price target, implying a 138.1% upside from current levels. In a report issued on May 20, Guggenheim also upgraded the stock to Buy with a $115.00 price target.

Ayr Wellness (AYRWF)

In a report released today, Pablo Zuanic from Cantor Fitzgerald maintained a Hold rating on Ayr Wellness, with a price target of $6.75. The company’s shares closed last Thursday at $6.40, close to its 52-week low of $4.61.

According to TipRanks.com, Zuanic is ranked #984 out of 7919 analysts.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Ayr Wellness with a $25.55 average price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on AMED:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More
Videos
---

Latest News Feed